Francine Watson

Bachelor of Medicine and Bachelor of Science,  Charité - Universitätsmedizin Berlin 

Location: India

Consulting Services

Scientific Writing Admin and Customer Support Hospital-Pharmacy-Insurance Legal Support Data Science-Bioinformatics

Areas Of Interest

Vardenafil Nucleus, Dorsal Oculomotor Graft Versus Host Disease Puberties, Familial Precocious Cystectomies Sleep Sensory Paroxysm Oxidoreductases, Primary Amine Semiochemicals Incisions, Surgical Hepatitis A virus X-Linked Lymphoproliferative Disorder Toprol XL Angiotensin II, Sar(1)-Ala(8)- Benzo(a)pyrene 7,8-Dihydrodiol 9,10-Epoxide cis-Diammine(cyclobutanedicarboxylato)platinum II UDP Galactose-N-Acylsphingosine Galactosyltransferase Cymbalta Punica granatum Same-Sex Marriages Vipers, Gaboon West Nile Fever Meningoencephalitis Alcohol Related Polyneuropathy Tics, Gestural Molsidomin Stada APOBEC3G Protein Embryologic Gene Expression Regulation Model, Neural Network Reemerging Infectious Diseases Man-Made Satellite Reality, Virtual

Professional Narrative

Dr. Francine Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Executive Director, Harvard Med 1999
Executive Director, Amgen 2013

Education

Master of Science in physician assistant, Perelman School of Medicine 1991
Doctor of medicine, Weill Medical College 1994

Referees

Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02